← Leaderboards
Stuart Johnston Knechtle
University Of Wisconsin Madison
$31,693,968
Attributed
$31,915,343
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$62,772,602 · 20
By mechanism
U19$40,501,705 · 5
U01$17,831,215 · 3
R01$2,930,981 · 3
T32$788,678 · 1
R21$442,750 · 1
P51$277,273 · 7
Top collaborators
- Jean Kwun2 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- William J Burlingham$9,912,734
Others in their field
Top investigators on “Kidney Transplantation”
- Peter Scott Heeger · Case Western Reserve University$86,758,000
- Joren C Madsen · Massachusetts General Hospital$51,129,981
- Dorry Segev · Johns Hopkins University$40,143,271
- Peter G Stock · University Of California San Francisco$37,405,503
- Robert M Merion · University Of Michigan At Ann Arbor$29,566,275
- John C Magee · University Of Michigan At Ann Arbor$28,786,531
Research focus
Kidney TransplantationTransplantationT-LymphocyteResponseTransplant RecipientsMacaca MulattaNonhuman PrimatePreventImmuneMediatingAntibodiesOrgan TransplantationCellsImmune ResponsePharmaceutical PreparationsImmunosuppressive AgentsB-LymphocytesIsoantibodiesKidney AllograftBaseAntigensLifeMonitorDesensitization
Grant awards (60)
The Risks and Opportunities of Homeostatic Repopulation$3,208,387
U19 · FY2025 · AI · contact PI
Targeting the B Cell Response to Treat Antibody-Mediated Rejection$2,489,690
U01 · FY2025 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$3,208,377
U19 · FY2024 · AI · contact PI
Targeting the B Cell Response to Treat Antibody-Mediated Rejection$2,573,144
U01 · FY2024 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$3,275,730
U19 · FY2023 · AI · contact PI
Targeting the B Cell Response to Treat Antibody-Mediated Rejection$2,582,477
U01 · FY2023 · AI · contact PI
Targeting the B Cell Response to Treat Antibody-Mediated Rejection$2,582,477
U01 · FY2022 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$1,725,847
U19 · FY2022 · AI · contact PI
Depletion, Repopulation and Tolerance in Sensitized Recipients$733,697
U19 · FY2022 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$2,434,257
U19 · FY2021 · AI · contact PI
Targeting the B Cell Response to Treat Antibody-Mediated Rejection$1,561,304
U01 · FY2021 · AI · contact PI
Depletion, Repopulation and Tolerance in Sensitized Recipients$1,094,006
U19 · FY2021 · AI · contact PI
Measuring the Impact of Allosensitization on Xenotransplantation$201,250
R21 · FY2021 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$2,802,151
U19 · FY2020 · AI · contact PI
Depletion, Repopulation and Tolerance in Sensitized Recipients$1,251,943
U19 · FY2020 · AI · contact PI
Measuring the Impact of Allosensitization on Xenotransplantation$241,500
R21 · FY2020 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$2,434,258
U19 · FY2019 · AI · contact PI
Depletion, Repopulation and Tolerance in Sensitized Recipients$1,033,869
U19 · FY2019 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$2,434,258
U19 · FY2018 · AI · contact PI
Depletion, Repopulation and Tolerance in Sensitized Recipients$1,055,736
U19 · FY2018 · AI · contact PI
The Risks and Opportunities of Homeostatic Repopulation$2,434,259
U19 · FY2017 · AI · contact PI
Depletion, Repopulation and Tolerance in Sensitized Recipients$1,085,214
U19 · FY2017 · AI · contact PI
Developing Tolerance Approaches to Overcome Humoral Immunity$867,143
U19 · FY2016 · AI · contact PI
Developing Tolerance Approaches to Overcome Humoral Immunity$517,958
U19 · FY2015 · AI · contact PI
Developing Tolerance Approaches to Overcome Humoral Immunity$598,463
U19 · FY2014 · AI · contact PI
Transplant Tolerance in Non-Human Primates$3,407,638
U19 · FY2013 · AI · contact PI
Developing Tolerance Approaches to Overcome Humoral Immunity$737,692
U19 · FY2013 · AI · contact PI
Transplant Tolerance in Non-Human Primates$3,492,097
U19 · FY2012 · AI · contact PI
Developing Tolerance Approaches to Overcome Humoral Immunity$668,725
U19 · FY2012 · AI · contact PI
Memory and Regulatory T Cells Following T Cell Depletion in Transplantation$758,780
U01 · FY2011 · AI · contact PI
MEMORY AND REGULATORY T CELLS FOLLOWING T CELL DEPLETION IN TRANSPLANTATION$41,159
P51 · FY2011 · RR · contact PI
Memory and Regulatory T Cells Following T Cell Depletion in Transplantation$727,576
U01 · FY2010 · AI · contact PI
MEMORY AND REGULATORY T CELLS FOLLOWING T CELL DEPLETION IN TRANSPLANTATION$54,827
P51 · FY2010 · RR · contact PI
Memory and Regulatory T Cells Following T Cell Depletion in Transplantation$713,519
U01 · FY2009 · AI · contact PI
RENAL TRANSPLANTATION GRAFT SURVIVAL$46,835
P51 · FY2009 · RR · contact PI
Memory and Regulatory T Cells Following T Cell Depletion in Transplantation$692,368
U01 · FY2008 · AI · contact PI
RENAL TRANSPLANTATION GRAFT SURVIVAL$40,957
P51 · FY2008 · RR · contact PI
Memory and Regulatory T Cells Following T Cell Depletion in Transplantation$650,202
U01 · FY2007 · AI · contact PI
Campath-1H & Calcineurin-Inhibitors in Renal Transplant$340,155
R01 · FY2007 · DK · contact PI
RENAL TRANSPLANTATION GRAFT SURVIVAL$31,485
P51 · FY2007 · RR · contact PI
CXCR3 Chemokine Receptor in Non-Human Primate Allograft$526,561
U01 · FY2006 · AI · contact PI
Campath-1H & Calcineurin-Inhibitors in Renal Transplant$351,647
R01 · FY2006 · DK · contact PI
U. of Wisconsin Transplant Research Training Program$170,410
T32 · FY2006 · AI · contact PI
RENAL TRANSPLANTATION GRAFT SURVIVAL$27,215
P51 · FY2006 · RR · contact PI
CXCR3 Chemokine Receptor in Non-Human Primate Allograft$523,527
U01 · FY2005 · AI
Campath-1H &Calcineurin-Inhibitors in Renal Transplant$363,750
R01 · FY2005 · DK
U. of Wisconsin Transplant Research Training Program$168,521
T32 · FY2005 · AI
PROLONGING GRAFT SURVIVAL IN A MODEL OF RENAL TRANSPLANTATION IN BABOONS$34,795
P51 · FY2005 · RR
CXCR3 Chemokine Receptor in Non-Human Primate Allograft$508,279
U01 · FY2004 · AI
Campath-1H &Calcineurin-Inhibitors in Renal Transplant$363,750
R01 · FY2004 · DK
U. of Wisconsin Transplant Research Training Program$171,923
T32 · FY2004 · AI
CXCR3 Chemokine Receptor in Non-Human Primate Allograft$496,914
U01 · FY2003 · AI
Renal Transplantation Using Campath1H/Rapamycin$291,000
R01 · FY2003 · AI
U. of Wisconsin Transplant Research Training Program$169,276
T32 · FY2003 · AI
CXCR3 Chemokine Receptor in Non-Human Primate Allograft$444,397
U01 · FY2002 · AI
Renal Transplantation Using Campath1H/Rapamycin$261,900
R01 · FY2002 · AI
U. of Wisconsin Transplant Research Training Program$108,548
T32 · FY2002 · AI
TRANSPLANTATION TOLERANCE USING IMMUNOTOXIN$346,207
R01 · FY2001 · AI
Renal Transplantation Using Campath1H/Rapamycin$276,450
R01 · FY2001 · AI
TRANSPLANTATION TOLERANCE USING IMMUNOTOXIN$336,122
R01 · FY2000 · AI